MW05

· Mabwell (Shanghai) Bioscience Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MW05, covering 2022-12-02 to 2022-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF [Phase 2, Phase 3]